1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study
Background In patients with coronavirus disease 2019 (COVID-19) requiring supplemental oxygen, dexamethasone reduces acute severity and improves survival, but longer-term effects are unknown. We hypothesised that systemic corticosteroid administration during acute COVID-19 would be associated with i...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
European Respiratory Society
2024-09-01
|
| シリーズ: | ERJ Open Research |
| オンライン・アクセス: | http://openres.ersjournals.com/content/10/5/00474-2024.full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
